Literature DB >> 31088912

Elucidating Tau function and dysfunction in the era of cryo-EM.

Guy Lippens1, Benoît Gigant2.   

Abstract

Tau is a microtubule-associated protein involved in the regulation of axonal microtubules in neurons. In pathological conditions, it forms fibrils that are molecular hallmarks of neurological disorders known as tauopathies. In the last 2 years, cryo-EM has given unprecedented high-resolution views of Tau in both physiological and pathological conditions. We review here these new findings and put them into the context of the knowledge about Tau before this structural breakthrough. The first structures of Tau fibrils, a molecular hallmark of Alzheimer's disease (AD), were based on fibrils from the brain of an individual with AD and, along with similar patient-derived structures, have set the gold standard for the field. Cryo-EM structures of Tau fibers in three distinct diseases, AD, Pick's disease, and chronic traumatic encephalopathy, represent the end points of Tau's molecular trajectory. We propose that the recent Tau structures may call for a re-examination of databases that link different Tau variants to various forms of dementia. We also address the question of how this structural information may link Tau's functional and pathological aspects. Because this structural information on Tau was obtained in a very short period, the new structures should be viewed in light of earlier structural observations and past and present functional data to shed additional light on Tau function and dysfunction.
© 2019 Lippens and Gigant.

Entities:  

Keywords:  Alzheimer's disease; Tau protein (Tau); amyloid; cryo-electron microscopy; frontotemporal dementia; microtubule; neurodegeneration; tauopathy; tubulin

Mesh:

Substances:

Year:  2019        PMID: 31088912      PMCID: PMC6579466          DOI: 10.1074/jbc.REV119.008031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  91 in total

1.  ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY.

Authors:  M KIDD
Journal:  Brain       Date:  1964-06       Impact factor: 13.501

2.  Acetylation of tau inhibits its degradation and contributes to tauopathy.

Authors:  Sang-Won Min; Seo-Hyun Cho; Yungui Zhou; Sebastian Schroeder; Vahram Haroutunian; William W Seeley; Eric J Huang; Yong Shen; Eliezer Masliah; Chandrani Mukherjee; David Meyers; Philip A Cole; Melanie Ott; Li Gan
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

Review 3.  Cryo-EM in drug discovery: achievements, limitations and prospects.

Authors:  Jean-Paul Renaud; Ashwin Chari; Claudio Ciferri; Wen-Ti Liu; Hervé-William Rémigy; Holger Stark; Christian Wiesmann
Journal:  Nat Rev Drug Discov       Date:  2018-06-08       Impact factor: 84.694

Review 4.  The emerging link between O-GlcNAc and Alzheimer disease.

Authors:  Yanping Zhu; Xiaoyang Shan; Scott A Yuzwa; David J Vocadlo
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

5.  A Phosphorylation-Induced Turn Defines the Alzheimer's Disease AT8 Antibody Epitope on the Tau Protein.

Authors:  Neha S Gandhi; Isabelle Landrieu; Cillian Byrne; Predrag Kukic; Laziza Amniai; François-Xavier Cantrelle; Jean-Michel Wieruszeski; Ricardo L Mancera; Yves Jacquot; Guy Lippens
Journal:  Angew Chem Int Ed Engl       Date:  2015-04-16       Impact factor: 15.336

Review 6.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

7.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease.

Authors:  Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Gerald W Hart; Cheng-Xin Gong
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  FTDP-17 mutations in Tau alter the regulation of microtubule dynamics: an "alternative core" model for normal and pathological Tau action.

Authors:  Adria C LeBoeuf; Sasha F Levy; Michelle Gaylord; Arnab Bhattacharya; Ambuj K Singh; Mary Ann Jordan; Leslie Wilson; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2008-10-21       Impact factor: 5.157

9.  Spin Labeling and Characterization of Tau Fibrils Using Electron Paramagnetic Resonance (EPR).

Authors:  Virginia Meyer; Martin Margittai
Journal:  Methods Mol Biol       Date:  2016

10.  Cryo-EM structure of alpha-synuclein fibrils.

Authors:  Ricardo Guerrero-Ferreira; Nicholas Mi Taylor; Daniel Mona; Philippe Ringler; Matthias E Lauer; Roland Riek; Markus Britschgi; Henning Stahlberg
Journal:  Elife       Date:  2018-07-03       Impact factor: 8.140

View more
  12 in total

Review 1.  Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

Authors:  Justin M Long; David M Holtzman
Journal:  Cell       Date:  2019-09-26       Impact factor: 41.582

Review 2.  Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools.

Authors:  Isabelle Landrieu; Elian Dupré; Davy Sinnaeve; Léa El Hajjar; Caroline Smet-Nocca
Journal:  Front Chem       Date:  2022-05-12       Impact factor: 5.545

3.  Structure-Activity Relationships of Novel Tau Ligands: Passive Fibril Binders and Active Aggregation Inhibitors.

Authors:  David W Baggett; Abhinav Nath
Journal:  ACS Chem Biol       Date:  2022-02-11       Impact factor: 4.634

Review 4.  Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.

Authors:  Phuong H Nguyen; Ayyalusamy Ramamoorthy; Bikash R Sahoo; Jie Zheng; Peter Faller; John E Straub; Laura Dominguez; Joan-Emma Shea; Nikolay V Dokholyan; Alfonso De Simone; Buyong Ma; Ruth Nussinov; Saeed Najafi; Son Tung Ngo; Antoine Loquet; Mara Chiricotto; Pritam Ganguly; James McCarty; Mai Suan Li; Carol Hall; Yiming Wang; Yifat Miller; Simone Melchionna; Birgit Habenstein; Stepan Timr; Jiaxing Chen; Brianna Hnath; Birgit Strodel; Rakez Kayed; Sylvain Lesné; Guanghong Wei; Fabio Sterpone; Andrew J Doig; Philippe Derreumaux
Journal:  Chem Rev       Date:  2021-02-05       Impact factor: 60.622

5.  A theoretical study of polymorphism in VQIVYK fibrils.

Authors:  Jaehoon Yang; Mithila V Agnihotri; Carol J Huseby; Jeff Kuret; Sherwin J Singer
Journal:  Biophys J       Date:  2021-02-09       Impact factor: 4.033

Review 6.  The Cryo-EM Effect: Structural Biology of Neurodegenerative Disease Aggregates.

Authors:  Benjamin C Creekmore; Yi-Wei Chang; Edward B Lee
Journal:  J Neuropathol Exp Neurol       Date:  2021-06-04       Impact factor: 3.148

Review 7.  Cellular Biology of Tau Diversity and Pathogenic Conformers.

Authors:  Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Lenka Hromadkova; Jiri G Safar; David Westaway
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

8.  A novel structure associated with aging is augmented in the DPP6-KO mouse brain.

Authors:  Lin Lin; Ronald S Petralia; Ross Lake; Ya-Xian Wang; Dax A Hoffman
Journal:  Acta Neuropathol Commun       Date:  2020-11-23       Impact factor: 7.801

9.  Proteomic Profiling of Extracellular Vesicles Separated from Plasma of Former National Football League Players at Risk for Chronic Traumatic Encephalopathy.

Authors:  Satoshi Muraoka; Annina M DeLeo; Zijian Yang; Harutsugu Tatebe; Kayo Yukawa-Takamatsu; Seiko Ikezu; Takahiko Tokuda; David Issadore; Robert A Stern; Tsuneya Ikezu
Journal:  Aging Dis       Date:  2021-09-01       Impact factor: 6.745

Review 10.  Risk of Transmissibility From Neurodegenerative Disease-Associated Proteins: Experimental Knowns and Unknowns.

Authors:  David M Asher; Ermias Belay; Eileen Bigio; Sebastian Brandner; Scott A Brubaker; Byron Caughey; Brychan Clark; Inger Damon; Marc Diamond; Michelle Freund; Bradley T Hyman; Mathias Jucker; C Dirk Keene; Andrew P Lieberman; Miroslaw Mackiewicz; Thomas J Montine; Susan Morgello; Creighton Phelps; Jiri Safar; Julie A Schneider; Lawrence B Schonberger; Christina Sigurdson; Nina Silverberg; John Q Trojanowski; Matthew P Frosch
Journal:  J Neuropathol Exp Neurol       Date:  2020-11-01       Impact factor: 3.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.